Pulmonary arterial hypertension and MicroRNAs-an ever-growing partnership

Archives of Medical Research

Volumn 44, Issue 7, 2013, Pages 483-487

  Wang, Yong ^a   Xue, Xin ying ^a   Liu, Yu xia ^b   Wang, Kai fei ^c   Zang, Xue feng ^a   Wang, Jing ^a   Wang, Pei lan ^c   Zhang, Jie ^a   Pan, Lei ^a   Zhang, Shu yang ^b   Wang, Jian xin ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Hypertension; MicroRNAs; Pulmonary arterial hypertension; Pulmonary hypertension; Vascular remodeling

Indexed keywords

BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; INTERLEUKIN 6; MICRORNA; MICRORNA 100; MICRORNA 143; MICRORNA 145; MICRORNA 17; MICRORNA 204; MICRORNA 20A; MICRORNA 21; MICRORNA 22; MICRORNA 27A; MICRORNA 30; MICRORNA 451; MICRORNA 92; MICRORNA LET 7A; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ASYMPTOMATIC DISEASE; CELL PROLIFERATION; DISEASE COURSE; DRUG TARGETING; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; MUSCLE CONTRACTILITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RESISTANCE BLOOD VESSEL; REVIEW; VASCULAR RESISTANCE;

EID: 84887155678     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.08.003     Document Type: Review

References (35)

1. Fukumoto Y., Shimokawa H. Recent progress in the management of pulmonary hypertension. Circ J 2011, 75:1801-1810.
2. Simonneau G., Galiè N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004, 43:5S-12S.
3. Diller G.P., Gatzoulis M.A. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007, 115:1039-1050.
4. McLaughlin V.V., McGoon M.D. Pulmonary arterial hypertension. Circulation 2006, 114:1417-1431.
5. Evdokimova V., Tognon C., Ng T., et al. Translational activation of Snail and other developmentally regulated transcription factors by YB-1 promotes an epithelial-to-mesenchymal transition. Cancer Cell 2009, 15:402-415.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Ambros V., Bartel B., Bartel D.P., et al. A uniform system for microRNA annotation. RNA 2003, 9:277-279.
8. Doench J.G., Sharp P.A. Specificity of microRNA target selection in translational repression. Gene Dev 2004, 18:504-511.
9. Caruso P., MacLean M.R., Khanin R., et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 2010, 30:716-723.
10. Courboulin A., Tremblay V.L., Barrier M., et al. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res 2011, 12:128.
11. Drake K.M., Zygmunt D., Mavrakis L., et al. Altered microRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Am J Respir Crit Care Med 2011, 184:1400-1408.
12. Brock M., Trenkmann M., Gay R.E., et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 2009, 104:1184-1191.
13. Pullamsetti S.S., Doebele C., Fischer A., et al. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 2012, 185:409-419.
14. Bockmeyer C.L., Maegel L., Janciauskiene S., et al. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant 2012, 31:764-772.
15. Jonigk D., Golpon H., Bockmeyer C.L., et al. Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol 2011, 179:167-179.
16. Parikh V.N., Jin R.C., Rabello S., et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 2012, 125:1520-1532.
17. Cordes K.R., Sheehy N.T., White M.P., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
18. Caruso P., Dempsie Y., Stevens H.C., et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res 2012, 111:290-300.
19. Reinhart B.J., Slack F.J., Basson M., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
20. Stark A., Brennecke J., Bushati N., et al. Animal microRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 2005, 123:1133-1146.
21. Dostie J., Mourelatos Z., Yang M., et al. Numerous microRNPs in neuronal cells containing novel microRNAs. RNA 2003, 9:180-186.
22. Rabinovitch M., Gamble W., Nadas A.S., et al. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979, 236:H818-H827.
23. Meyrick B., Gamble W., Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol 1980, 239:H692-H702.
24. Stenmark K.R., Fasules J., Hyde D.M., et al. Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol 1987, 62:821-830.
25. Perkett E.A., Brigham K.L., Meyrick B. Continuous air embolization into sheep causes sustained pulmonary hypertension and increased pulmonary vasoreactivity. Am J Pathol 1988, 132:444-454.
26. Rondelet B., Kerbaul F., Motte S., et al. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 2003, 107:1329-1335.
27. Garcia R., Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 1990, 24:430-432.
28. Dai Z.K., Tan M.S., Chai C.Y., et al. Effects of increased pulmonary flow on the expression of endothelial nitric oxide synthase and endothelin-1 in the rat. Clin Sci (Lond) 2002, 103:289S-293S.
29. Lam C.F., Peterson T.E., Croatt A.J., et al. Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2005, 289:H2334-H2341.
30. Tanaka Y., Schuster D.P., Davis E.C., et al. The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. J Clin Invest 1996, 98:434-442.
31. Okada K., Tanaka Y., Bernstein M., et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 1997, 151:1019-1025.
32. Ciuclan L., Bonneau O., Hussey M., et al. A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2011, 184:1171-1182.
33. Krichevsky A.M., Gabriely G. miR-21: a small multi-faceted MA. J Cell Mol Med 2009, 13:39-53.
34. Selcuklu S.D., Donoghue M.T., Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009, 37:918-925.
35. Liu G., Friggeri A., Yang Y., et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010, 207:1589-1597.